These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3667006

  • 1. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V, Nicora M, Beretta A.
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [Abstract] [Full Text] [Related]

  • 2. [Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].
    Gandola L, Aiolfi S, Soccini F, Patrini G, Capellini G, Scartabellati A, Ghio L, Mauri F.
    Clin Ter; 1989 Dec 15; 131(5):293-7. PubMed ID: 2532583
    [Abstract] [Full Text] [Related]

  • 3. Long-term therapy with sustained-release theophylline.
    Myhre KI, Arnulf V, Walstad RA.
    Pharmatherapeutica; 1985 Dec 15; 4(2):92-7. PubMed ID: 3903782
    [Abstract] [Full Text] [Related]

  • 4. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G, Cresci F, Lo Sapio P, Panuccio P.
    Int J Clin Pharmacol Res; 1987 Dec 15; 7(5):351-6. PubMed ID: 3667008
    [Abstract] [Full Text] [Related]

  • 5. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV, Nonikov VE, Belousov IuB.
    Ter Arkh; 1993 Dec 15; 65(8):41-4. PubMed ID: 8211801
    [Abstract] [Full Text] [Related]

  • 6. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
    Chuchalin AG, Tsoĭ AN, Zaĭtseva TM, Titova EV, Medani SM, Smirnov MV, Kaziakhmedov EA.
    Ter Arkh; 1995 Dec 15; 67(6):26-9. PubMed ID: 7667774
    [Abstract] [Full Text] [Related]

  • 7. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
    Melillo G, Balzano G, Jodice F, De Felice A, Campisi V, Capone M, Di Filippo A, Foddai G, Franzone JS, Grossi E.
    Int J Clin Pharmacol Res; 1989 Dec 15; 9(6):397-405. PubMed ID: 2699466
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A, Verdiani P, Di Carlo S.
    Clin Ter; 1987 Sep 30; 122(6):437-40. PubMed ID: 2972456
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction.
    Sahay JN, Chatterjee SS, Summerfield PJ.
    Br J Clin Pract; 1986 May 30; 40(5):198-202. PubMed ID: 2944533
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG, Bruzzoni A, Valenti V.
    Clin Ter; 1989 Jul 15; 130(1):45-9. PubMed ID: 2529079
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ.
    Med Klin Prax; 1982 Aug 27; 77(18):48-53, 67. PubMed ID: 6752679
    [Abstract] [Full Text] [Related]

  • 17. [Clinical effectiveness of delayed-action theophylline preparations].
    Tsoĭ AN, Gavrilenko LN, Bogovskiĭ BP, Semenova LG, Iuldasheva LI.
    Klin Med (Mosk); 1990 Sep 27; 68(9):72-5. PubMed ID: 2290338
    [Abstract] [Full Text] [Related]

  • 18. [Possibilities for optimizing therapy with theophylline preparations. Clinical effectiveness and side effects of microcrystalline theophylline].
    Wiesner B, Sehrt I, Iwainsky H.
    Z Erkr Atmungsorgane; 1984 Sep 27; 162(1):11-7. PubMed ID: 6426180
    [Abstract] [Full Text] [Related]

  • 19. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D.
    Br J Clin Pract Suppl; 1984 Sep 27; 32():14-7. PubMed ID: 6432017
    [No Abstract] [Full Text] [Related]

  • 20. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ, Demers L, Esler V, Field E.
    Clin Ther; 1981 Sep 27; 4(4):252-62. PubMed ID: 7332913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.